• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中脊柱融合使用骨生物材料的并发症和关注点。

Complications and concerns with osteobiologics for spine fusion in clinical practice.

机构信息

Department of Orthopaedic Surgery, University of Louisville School of Medicine, Louisville, KY, USA.

出版信息

Spine (Phila Pa 1976). 2010 Aug 1;35(17):1621-8. doi: 10.1097/BRS.0b013e3181ce11cc.

DOI:10.1097/BRS.0b013e3181ce11cc
PMID:20628338
Abstract

STUDY DESIGN

Literature-based topic review.

OBJECTIVE

To review the complications and the concerns that may be associated with all of the commonly used osteobiologic options for spine fusion.

SUMMARY OF BACKGROUND DATA

Obtaining a solid arthrodesis is an important objective in many lumbar surgical procedures, and a wide array of bone graft materials may be used in an attempt to achieve this goal. Iliac crest bone graft, as well as all of the available osteobiologic alternatives, carries potential risks and concerns for both patient and surgeon.

METHODS

Review of literature and expert opinion.

CONCLUSION

Some of the potential complications associated with osteobiologic materials used in spinal fusion are well understood and clearly documented whereas others require further study and clarification. In any given clinical situation, the patient and surgeon need to balance the benefits and performance characteristics of the graft material with the risk profile to optimize clinical management.

摘要

研究设计

基于文献的主题回顾。

目的

回顾与脊柱融合常用的所有骨生物制剂相关的并发症和关注点。

背景资料概要

在许多腰椎手术中,获得可靠的融合是一个重要目标,可使用多种骨移植物材料来实现这一目标。骼嵴骨移植物以及所有可用的骨生物替代物,对患者和外科医生都存在潜在的风险和担忧。

方法

文献回顾和专家意见。

结论

与脊柱融合中使用的骨生物材料相关的一些潜在并发症已经得到充分理解和明确记录,而其他并发症则需要进一步研究和澄清。在任何特定的临床情况下,患者和外科医生需要平衡移植物材料的益处和性能特点与风险状况,以优化临床管理。

相似文献

1
Complications and concerns with osteobiologics for spine fusion in clinical practice.临床实践中脊柱融合使用骨生物材料的并发症和关注点。
Spine (Phila Pa 1976). 2010 Aug 1;35(17):1621-8. doi: 10.1097/BRS.0b013e3181ce11cc.
2
Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.重组人骨形态发生蛋白-2负载可吸收胶原海绵与髂嵴植骨用于颈椎后路融合术的围手术期并发症
Spine (Phila Pa 1976). 2009 Jun 1;34(13):1390-4. doi: 10.1097/BRS.0b013e3181a2da08.
3
Graft options in posterolateral and posterior interbody lumbar fusion.后路腰椎体间融合术中的植骨选择。
Spine (Phila Pa 1976). 2010 Aug 1;35(17):1629-39. doi: 10.1097/BRS.0b013e3181d25803.
4
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.OP-1(重组人骨形态发生蛋白-7)替代髂嵴自体骨用于腰椎后外侧融合术的安全性和有效性:一项初步研究的至少4年随访
Spine J. 2008 May-Jun;8(3):457-65. doi: 10.1016/j.spinee.2007.03.012. Epub 2007 May 25.
5
Gluteal-sparing approach for posterior iliac crest bone graft: description of a new technique and assessment of morbidity in ninety-two patients after spinal fusion.臀肌保留的髂后嵴骨移植入路:后路脊柱融合术后 92 例患者的新术式描述及发病率评估。
Spine (Phila Pa 1976). 2010 Jun 15;35(14):1396-400. doi: 10.1097/BRS.0b013e3181cabf69.
6
Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.单节段器械辅助后外侧融合术中使用重组人骨形态发生蛋白-2/抗压基质与髂嵴骨移植在2年时的临床疗效及融合成功率
Spine (Phila Pa 1976). 2006 Oct 15;31(22):2534-9; discussion 2540. doi: 10.1097/01.brs.0000240715.78657.81.
7
Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion.髂嵴取骨中的假性疾病:重组人骨形态发生蛋白-2在短节段腰椎后路融合中的兴起
Spine J. 2009 Nov;9(11):873-9. doi: 10.1016/j.spinee.2009.09.001.
8
Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion.同种异体移植物联合骨形态发生蛋白与髂嵴自体骨移植在前路颈椎间盘切除融合术中的前瞻性非随机比较。
Spine J. 2008 May-Jun;8(3):426-35. doi: 10.1016/j.spinee.2006.12.006. Epub 2007 Mar 7.
9
Bone grafting options in children.儿童的植骨选择。
Spine (Phila Pa 1976). 2010 Aug 1;35(17):1648-54. doi: 10.1097/BRS.0b013e3181ce8f4b.
10
Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.使用重组人骨形态发生蛋白-2(rhBMP-2)与自体髂嵴骨移植进行成人长节段脊柱畸形融合至骶骨的比较。
Spine (Phila Pa 1976). 2009 Sep 15;34(20):2205-12. doi: 10.1097/BRS.0b013e3181b0485c.

引用本文的文献

1
Global Practices and Preferences in the Use of Osteobiologics for Anterior Cervical Discectomy and Fusion: A Cross-Sectional Study.用于颈椎前路椎间盘切除融合术的骨生物制剂使用的全球实践与偏好:一项横断面研究。
Global Spine J. 2025 Feb 19:21925682251322417. doi: 10.1177/21925682251322417.
2
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages.IL-1β 促进破骨细胞分泌骨硬化蛋白,靶向骨硬化蛋白可促进早期脊柱融合。
J Orthop Surg Res. 2023 Mar 3;18(1):162. doi: 10.1186/s13018-023-03657-0.
3
The Impact of Osteobiologic Subtype Selection on Perioperative Complications and Hospital-Reported Charges in Single- and Multi-Level Lumbar Spinal Fusion.
骨生物亚型选择对单节段和多节段腰椎融合术围手术期并发症及医院报告费用的影响
Int J Spine Surg. 2021 Aug;15(4):654-662. doi: 10.14444/8086. Epub 2021 Jul 15.
4
Use of Autologous Stem Cells in Lumbar Spinal Fusion: A Systematic Review of Current Clinical Evidence.自体干细胞在腰椎融合术中的应用:当前临床证据的系统评价
Global Spine J. 2021 Oct;11(8):1281-1298. doi: 10.1177/2192568220973190. Epub 2020 Nov 18.
5
Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2.使用重组人骨形态发生蛋白-2的腰椎外侧椎间融合术的融合率
Global Spine J. 2019 Jun;9(4):398-402. doi: 10.1177/2192568218797097. Epub 2018 Sep 25.
6
Allograft Versus Demineralized Bone Matrix in Instrumented and Noninstrumented Lumbar Fusion: A Systematic Review.器械辅助与非器械辅助腰椎融合术中同种异体骨与脱矿骨基质的比较:一项系统评价
Global Spine J. 2018 Jun;8(4):396-412. doi: 10.1177/2192568217735342. Epub 2017 Oct 25.
7
Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?重组人骨形态发生蛋白-2在后外侧脊柱融合术中的应用:合适的剂量是多少?
Asian Spine J. 2016 Jun;10(3):457-64. doi: 10.4184/asj.2016.10.3.457. Epub 2016 Jun 16.
8
Prospective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological study.一种新型骨移植材料用于腰椎椎间融合术的前瞻性分析:一项为期2年的前瞻性临床及影像学研究结果
Int J Spine Surg. 2015 Feb 3;9. doi: 10.14444/2002. eCollection 2015.
9
Transforaminal lumbar interbody fusion rates in patients using a novel titanium implant and demineralized cancellous allograft bone sponge.使用新型钛植入物和脱矿质松质骨同种异体骨海绵的患者的经椎间孔腰椎椎间融合率。
Int J Spine Surg. 2013 Dec;7(1):e95-e100. doi: 10.1016/j.ijsp.2013.08.001.
10
Rare complications of osteolysis and periprosthetic tissue reactions after hybrid and non-hybrid total disc replacement.混合式和非混合式全椎间盘置换术后骨溶解和假体周围组织反应的罕见并发症。
Eur Spine J. 2015 May;24 Suppl 4:S494-501. doi: 10.1007/s00586-014-3535-0. Epub 2014 Aug 28.